iTeos Therapeutics, Inc. Quarterly Revenues in USD from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
iTeos Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q3 2021 to Q2 2024.
  • iTeos Therapeutics, Inc. Revenues for the quarter ending June 30, 2024 was $35M.
  • iTeos Therapeutics, Inc. Revenues for the twelve months ending June 30, 2024 was $35M, a 59.3% decline year-over-year.
  • iTeos Therapeutics, Inc. annual Revenues for 2023 was $12.6M, a 95.3% decline from 2022.
  • iTeos Therapeutics, Inc. annual Revenues for 2022 was $268M, a 22.4% decline from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $35M $35M +$35M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $0 $0 -$12.6M -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $12.6M $0 -$53.9M -100% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $66.5M $0 -$19.5M -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $86M $0 -$41.7M -100% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $128M $12.6M -$140M -91.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $268M $53.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $19.5M -$84.8M -81.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $41.7M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $153M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q3 2021 $104M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.